Blood serum 5 type haemophilus parasuis and application thereof
A technology of Haemophilus suis and Haemophilus suis disease, which is applied in the direction of bacteria, antibacterial drugs, and medical raw materials derived from bacteria, can solve the problems of farmers increasing the amount of antibiotics, pig products exceeding the standard of antibiotics, and endangering health. Achieve stable biological performance, strong pathogenicity, and reduce economic losses
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0034] Example 1 Isolation and identification of serotype 5 Haemophilus parasuis
[0035] 1. Isolation of pathogenic bacteria
[0036] Use a sterile inoculation loop to sample fresh lungs, pericardial effusion, joint fluid and other disease materials of suspected pigs, streak inoculation on TSA medium (containing final concentration of 5% serum and 0.001% NAD), culture at 37°C Observe the growth after 24h~48h, and perform Gram staining microscopy on the suspected colonies. Pick a single colony, and use the partition streaking method on the TSA solid medium to perform 3 to 5 single colony purification cultures until there are no other bacteria.
[0037] 2. Identification of pathogenic bacteria
[0038] 2.1 NAD dependence test
[0039] In a Class II biological safety cabinet, use an inoculation loop to pick up single colonies of the above suspicious bacteria, horizontally streak it on a TSA plate without NAD, pick out Staphylococcus aureus and streak it vertically, and incubate at 37°C ...
Example Embodiment
[0058] Example 2 Preparation of white oil adjuvant inactivated vaccine
[0059] 1. Antigen preparation
[0060] Inoculate Haemophilus parasuis JX1002 strain on TSA solid medium for resuscitation, pass 3 consecutive generations to rejuvenate, inoculate the rejuvenated Haemophilus parasuis in TSB liquid medium, and cultivate in a shaker at 37°C for 12h-14h. As the seed solution, inoculate the seed solution in TSB liquid medium preheated to 37℃ by 1% of the total volume of the culture medium. Then, at 37℃, 180r / min shaking and expanding for 14h-16h, and measuring the bacterial solution by spectrophotometer OD 600 Value, based on the number of viable bacteria and OD 600 Value correlation standard curve formula to calculate the total bacterial content. Then add formaldehyde with a final concentration of 0.2% to the bacterial solution to inactivate the bacteria, and place it in a 37°C incubator to inactivate the bacteria for 14 to 16 hours. During the inactivation period, shake once eve...
Example Embodiment
[0063] Example 3 Preparation of aluminum gel adjuvant inactivated vaccine
[0064] The antigen preparation steps are as in Example 2.
[0065] Vaccine preparation:
[0066] Mix the qualified bacterial solution in inactivation test with the same amount of 20% sterile aluminum hydroxide saline diluent, let stand at room temperature for 24 hours, aspirate the supernatant at 1 / 2 of the total volume, and then add A solution of thimerosal with a final content of one part in 10,000. The content of bacteria in the finished vaccine is 2.0×10 9 CFU / mL, store at 4°C.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap